ST國醫(000516.SZ):擬向商洛交投轉讓商洛醫院99%股權
格隆匯3月8日丨ST國醫(000516.SZ)公佈,公司與商洛市交通投資建設有限責任公司(簡稱“商洛交投”)於2022年3月7日在陝西省商洛市簽署了《商洛國際醫學中心醫院有限公司股權轉讓框架協議》,公司擬將所持商洛國際醫學中心醫院有限公司(簡稱“商洛醫院”)99%的股權作價轉讓,商洛交投擬以貨幣資金受讓公司所持上述股權。
根據公司的發展戰略和投資計劃,公司近年來不斷整合優質資源,完善業務佈局,優化資產結構。目前,公司正在穩步推進醫療服務主業的發展,西安高新醫院、西安國際醫學中心醫院業務規模實現快速增長,公司以西安為中心打造的醫療健康服務核心優勢不斷增強。
該次擬進行的股權轉讓,有利於公司的長遠發展,公司在構建醫療健康產業領域將向高質量、研究型、多層次方向發展,有助於增強公司的核心競爭力和可持續發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.